Home Nanjing Wisemed Medical Technology Co., Ltd. Announcement on the Listing and Circulation of Restricted Shares from Initial Public Offering Offline Placement

Nanjing Wisemed Medical Technology Co., Ltd. Announcement on the Listing and Circulation of Restricted Shares from Initial Public Offering Offline Placement

Jan 13, 2021 04:00 CST Updated 04:00
VISHEE

Developer, Manufacturer, and Distributor of Rehabilitation Medical Devices

Original Title: NanjingVISHEENanjing Vishee Medical Technology Co., Ltd. Announcement on the Listing and Circulation of Restricted Shares from Offline Placement in the Initial Public Offering

Stock Code: 688580 Stock Abbreviation: VISHEE Announcement No.: 2021-002

Important Notice:

● The number of restricted shares available for circulation in this listing is 727,558;

● The listing and circulation date is January 21, 2021.

I. Types of Restricted Shares Becoming Tradable in This Listing

Pursuant to the Approval on the Registration of the Initial Public Offering of Nanjing Vishee Medical Technology Co., Ltd. (Zheng Jian Xu Ke [2020] No. 1213) issued by the China Securities Regulatory Commission on June 23, 2020, Nanjing Vishee Medical Technology Co., Ltd. (hereinafter referred to as the “Company” or “Vishee Medical”) was approved to publicly issue 17,086,667 shares of Renminbi ordinary shares (A-shares) to the public. The Company was listed on the STAR Market of the Shanghai Stock Exchange on July 21, 2020. Prior to the initial public offering, the Company’s total share capital was 51,260,000 shares; following the initial public offering, the total share capital amounted to 68,346,667 shares, including 15,675,643 unrestricted tradable shares and 52,671,024 restricted tradable shares.

The restricted shares becoming tradable in this instance are all restricted shares from the offline placement during the initial public offering (IPO). The lock-up period is six months from the date of the company’s stock listing. A total of 232 shareholders participating in the offline placement are involved, corresponding to 727,558 shares, representing 1.0645% of the company’s total share capital. For further details, please refer to the “Announcement on the Results of the Initial Public Offering and Listing on the STAR Market of Nanjing Vishee Medical Technology Co., Ltd.” disclosed by the company on the Shanghai Stock Exchange website (www.sse.com.cn) on July 14, 2020. The number of shares for which restrictions are lifted and which are applied for trading circulation is 727,558. As the lock-up period is about to expire, these shares will become tradable starting from January 21, 2021.

II. Changes in the Company’s Share Capital Since the Formation of the Restricted Shares Subject to This Listing and Circulation

The restricted shares becoming tradable in this listing belong to the offline placement restricted shares from the initial public offering. From the formation of the company’s IPO restricted shares to the date of this announcement, the company has not experienced any changes in its total share capital due to profit distribution or capitalization of reserves.

III. Relevant Commitments Regarding the Restricted Shares Subject to Listing and Circulation in This Offering

The restricted shares subject to this listing and circulation are those from the offline placement during the initial public offering. Each placee has committed that the lock-up period for the allocated shares shall be six months from the date of the company’s stock listing.

In addition to the aforementioned commitments, there are no other special commitments made by the shareholders of the restricted shares applying for listing and circulation this time.

As of the date of disclosure of this announcement, the shareholders applying for the removal of share transfer restrictions have strictly fulfilled their corresponding commitments, and there are no circumstances where unfulfilled commitments would affect the listing and circulation of these restricted shares.

IV. Verification Opinions of Intermediary Institutions

Upon verification, the sponsoring institutionChangjiang SecuritiesThe underwriting and sponsoring institution (hereinafter referred to as the “Sponsoring Institution”) holds the view that, as of the date of issuance of this verification opinion, the holders of restricted shares of VISHEE have strictly fulfilled all commitments made during the company’s initial public offering. The listing and circulation of these restricted shares comply with the requirements of relevant laws, regulations, and normative documents, including the Measures for the Continuous Supervision of Companies Listed on the STAR Market (Trial) and the Rules Governing the Listing of Stocks on the STAR Market of the Shanghai Stock Exchange. The information disclosure by the company regarding the restricted shares in question is truthful, accurate, and complete.

In summary, the sponsor has no objection to the listing and circulation of the restricted shares from the offline placement in VISHEE’s initial public offering.

V. Details of the Restricted Shares Listed for Circulation in This Offering

(1) The total number of restricted shares available for listing and circulation in this issuance is 727,558, accounting for 1.0645% of the company’s total share capital.

(II) The listing and circulation date is January 21, 2021.

(III) Detailed List of Restricted Shares Listed for Circulation

(4) Table on the Listing and Circulation of Restricted Shares

VI. Attachments to the Online Announcement

“Verification Opinion of Changjiang Securities Underwriting & Sponsorship Co., Ltd. on the Listing and Circulation of Restricted Shares from the Offline Placement in the Initial Public Offering of Nanjing Vishee Medical Technology Co., Ltd.”

Board of Directors, Nanjing Vishee Medical Technology Co., Ltd.

January 13, 2021